-
摘要:
目的 分析2010—2021年北京市海淀区户籍人口恶性肿瘤死亡特征及变化趋势,为恶性肿瘤防控提供参考依据。 方法 收集2010—2021年海淀区户籍人口恶性肿瘤死亡资料,计算构成比、死亡粗率及标化率、早死寿命损失(YLL)率及其标化率,应用Joinpoint回归模型估计平均年度变化趋势。 结果 2010—2021年海淀区户籍人口恶性肿瘤居全死因首位,全死因占比30.23%,年均粗死亡率142.47/10万,标化死亡率93.32/10万;粗死亡率男性高于女性,差异有统计学意义(t=11.18,P<0.05),各年份标化死亡率男性均高于女性;相比2010年,2021年恶性肿瘤死因构成降至26.77%(降幅−15.37%),总人群、男性、女性粗死亡率呈逐年上升趋势[平均年度变化百分比(AAPC)分别为1.62%、1.82%、1.42%,均P<0.01],标化死亡率呈逐年下降趋势(AAPC分别为−1.50%、−1.13%、−1.85%,均P<0.01)。 前10位死因以肺癌和消化道恶性肿瘤为主,前6位死因顺位基本无变化,依次为肺癌、结直肠癌、肝癌、胃癌、胰腺癌、乳腺癌;膀胱癌、乳腺癌、结直肠癌粗死亡率上升趋势显著(AAPC分别为4.56%、3.81%、3.80%,均P<0.001),肝癌呈逐年下降趋势(AAPC=−1.24%,P<0.05)。 YLL逐年增长,YLL率变化无统计学意义(AAPC=0.30%,P>0.05),标化YLL率呈逐年下降趋势(AAPC=−2.10%,P<0.05);结直肠癌、胰腺癌、膀胱癌、乳腺癌YLL率呈逐年上升趋势(AAPC分别为2.90%、2.60%、3.40%、1.90%,P<0.05),肝癌、胃癌呈逐年下降趋势(AAPC分别为−2.70%、−1.20%,P<0.05)。 结论 肺癌、消化系统恶性肿瘤是海淀区癌症死亡的主要原因,近年来主要恶性肿瘤死亡率的上升受人口老龄化影响较大,但与吸烟、环境污染、不良生活方式等相关的恶性肿瘤疾病负担仍较重。 因此,应针对不同性别、主要癌种及变化趋势采取综合性防控措施。 Abstract:Objective To analyze the characteristics and trends of malignant tumors mortality in local population inHaidian district of Beijing from 2010 to 2021, and provide reference for the prevention and control of malignant tumors. Methods The death data of malignant tumors in local residents in Haidian from 2010 to 2021 were collected, and the constituent ratio, crude and standardized mortality rate, year of life lost (YLL) rate and standardized YLL rate were calculated. Joinpoint regression model was used to estimate the average annual trend. Results Malignant tumors ranked first in all causes of death in local residents of Haidian from 2010 to 2021, with deaths accounting for 30.23%. The average annual crude mortality rate standardized mortality rate were 142.47/100 000 and 93.32/100 000 respectively. The crude mortality rate was higher in men than women, the difference was statistically significant (t=11.18, P<0.05), and the standardized mortality rates in all years were higher in men than in women. Compared with 2010, the proportion of malignant tumor deaths in 2021 decreased to 26.77% (−15.37%). The crude mortality of total population, in men and in women showed increasing trends year by year with average annual percentage change (AAPC) of 1.62%, 1.82% and1.42%, respectively (all P<0.01), while the standardized mortality showed decreasing trends year by year with AAPC of −1.50%, −1.13% and −1.85%, respectively (all P<0.01).The top 10 causes of death included lung cancer and digestive system malignant tumor, the top 6 causes of death remained unchanged, i.e. lung cancer, colorectal cancer, liver cancer, gastric cancer, pancreatic cancer and breast cancer. The crude mortality of bladder cancer, breast cancer and colorectal cancer increased significantly (AAPC=4.56%, 3.81%, 3.80%, all P<0.001), and the crude mortality of liver cancer decreased year by year (AAPC=−1.24%, P<0.05). The YLL increased year by year, the change in YLL rate had no significantce (AAPC=0.30%, P>0.05), while the standardized YLL rate showed a downward trend year by year (AAPC=−2.10%, P<0.05). The YLL rates of colorectal cancer, pancreatic cancer, bladder cancer and breast cancer increased year by year (AAPC=2.90%, 2.60%, 3.40%, 1.90%, all P<0.05), but the YLL rates of liver cancer and gastric cancer decreased year by year (AAPC=−2.70% and −1.20%, all P<0.05). Conclusion Lung cancer and digestive system malignant of cancer death in Haidian. In recent years, the rising mortality rate of major malignant tumor has been greatly affected by the aging of the population, but the burden of malignant tumors related to smoking, environmental pollution and poor lifestyle is still heavy. Therefore, it is necessary to take targeted prevention and control measures in different population, for different cancer type and according to cancer incidence trend. -
Key words:
- Malignant tumor /
- Mortality /
- Changing trend /
- Average annual percentage change /
- Year of life lost
-
表 1 2010-2021年北京市海淀区户籍居民恶性肿瘤死亡情况
Table 1. Death of malignant tumors in local residents in Haidian district, Beijing city, from 2010 to 2021
年份 男性 女性 总计 死亡数
(例)占总死亡
的百分比
(%)死亡率
(/10万)标化死亡率
(/10万)死亡数
(例)占总死亡
的百分比
(%)死亡率
(/10万)标化死亡率
(/10万)死亡数
(例)占总死亡
的百分比
(%)死亡率
(/10万)标化死亡率
(/10万)2010 1 615 32.40 146.11 108.29 1 199 30.65 111.86 86.88 2 814 31.63 129.25 98.09 2011 1 788 35.45 158.68 113.38 1 196 31.59 108.87 82.93 2 984 33.79 134.10 98.78 2012 1 759 33.40 152.67 106.31 1 272 30.62 112.70 84.24 3 031 32.18 132.89 95.69 2013 1 790 33.05 152.51 101.96 1 340 31.48 115.89 82.33 3 130 32.36 134.34 92.34 2014 1 880 31.56 157.94 98.98 1 419 31.19 120.42 82.04 3 299 31.40 139.28 90.97 2015 1 916 32.13 159.83 99.34 1 348 29.11 113.18 73.82 3 264 30.81 136.59 86.78 2016 2 033 31.34 169.36 101.82 1 487 29.36 124.12 79.72 3 520 30.47 146.77 90.89 2017 1 990 30.48 167.75 97.92 1 462 28.43 122.65 76.46 3 452 29.58 145.15 87.41 2018 2 163 31.38 183.41 107.08 1 496 27.43 125.54 76.13 3 659 29.63 154.32 91.72 2019 2 107 29.69 176.63 99.59 1 522 27.94 126.17 73.01 3 629 28.93 151.26 86.23 2020 2 103 28.97 175.64 96.58 1 635 27.35 134.84 75.71 3 738 28.24 155.12 85.98 2021 2 125 28.13 176.34 93.69 1 464 25.00 120.01 66.19 3 589 26.77 148.01 80.03 合计 23 269 31.25 164.93a 105.72 16 840 28.92 119.90 80.48 40 109 30.23 142.47 93.32 变化率(%) 31.58 −13.16 20.69 −13.48 22.10 −18.42 7.29 −23.81 27.54 −15.37 14.51 −18.41 AAPC(%) − −1.60 1.82 −1.13 − −1.80 1.42 −1.85 − −1.70 1.62 −1.50 t值 − −6.60 6.90 −3.60 − −7.00 4.50 −6.00 − −8.30 7.50 −6.30 P值 − <0.001 <0.001 0.005 − <0.001 0.001 < 0.001 − <0.001 < 0.001 < 0.001 注:a. 死亡率男性与女性比较,t =11.18,P<0.05;AAPC. 平均年度变化百分比;− 表示无数据 表 2 2010-2021年北京市海淀区主要恶性肿瘤死亡率变化趋势
Table 2. Trend in mortality of major malignant tumors in Haidian district, Beijing city, from 2010 to 2021
癌种 男性 女性 合计 顺位 粗死亡率 标化死亡率 顺位 粗死亡率 标化死亡率 顺位 粗死亡率 标化死亡率 AAPC
(%)t值 P值 AAPC
(%)t值 P值 AAPC
(%)t值 P值 AAPC
(%)t值 P值 AAPC
(%)t值 P值 AAPC
(%)t值 P值 肺癌 1 1.55 3.90 0.003 −1.18 −2.60 0.024 1 −0.10 −0.20 0.825 −3.86 −8.50 < 0.001 1 0.30 0.50 0.614 −2.27 −6.50 < 0.001 结肠、直肠癌 2 4.87 10.90 <0.001 2.33 4.40 0.001 2 2.52 4.60 0.001 −1.29 −2.20 0.053 2 3.80 9.80 < 0.001 0.60 1.30 0.219 肝癌 3 −0.29 −0.50 0.655 −3.67 −5.40 < 0.001 5 −3.26 −4.30 0.002 −6.67 −7.90 < 0.001 3 −1.24 −2.90 0.017 −4.42 −9.40 < 0.001 胃癌 4 −0.70 −1.70 0.130 −3.29 −4.70 0.001 6 0.00 0.00 0.989 −2.22 −3.10 0.011 4 −0.40 −1.20 0.261 −3.00 −3.70 < 0.001 胰腺癌 5 2.78 3.00 0.014 0.31 0.30 0.771 4 3.74 3.90 0.003 0.65 0.70 0.494 5 3.28 5.10 < 0.001 0.49 0.80 0.469 乳腺癌 13 −2.36 −0.50 0.662 −6.62 −0.70 0.527 3 3.62 6.80 < 0.001 0.69 1.20 0.251 6 3.81 7.50 < 0.001 0.73 1.30 0.223 食管癌 7 0.32 0.30 0.799 −1.92 −1.40 0.181 11 −1.85 −1.30 0.218 −5.51 −4.10 0.002 7 −0.34 −0.40 0.698 −2.71 −2.90 0.017 白血病 8 0.45 0.40 0.705 −1.86 −1.50 0.172 8 0.68 0.60 0.568 −1.89 −1.60 0.146 8 0.50 0.60 0.545 −0.10 −0.10 0.943 前列腺癌 6 3.81 4.50 0.001 −1.31 −2.30 0.046 − − − − − − − 9 3.58 4.30 0.002 −1.73 −2.80 0.018a 膀胱癌 9 4.85 4.70 0.001 0.71 0.70 0.515 12 4.46 2.60 0.025 −1.07 −0.60 0.582 10 4.56 5.60 < 0.001 −0.11 −0.10 0.911 脑及神经系统恶性肿瘤 10 1.58 1.70 0.126 −0.77 −0.60 0.563 9 2.25 1.30 0.210 −0.65 −0.40 0.690 11 1.94 2.10 0.064 −0.84 −0.80 0.453 卵巢癌 − − − − − − − 7 2.38 2.60 0.075 −0.05 0.00 0.966 12 2.60 2.20 0.056 0.04 0.00 0.974 宫颈癌 − − − − − − − 10 3.20 2.50 0.030 1.83 1.60 0.150 13 3.42 2.70 0.023a 2.03 1.70 0.113 注:AAPC. 平均年度变化百分比;−表示无数据 表 3 2010-2021年北京市海淀区户籍人口恶性肿瘤YLL总体变化情况
Table 3. Change of malignant tumor YLL in local residents in Haidian district, Beijing city, from 2010 to 2021
年份 YLL(人年) YLL率(/10万) 标化YLL率(/10万) 2010 65 592 3 012.68 2 218.75 2011 69 606 3 128.04 2 263.39 2012 71 107 3 117.64 2 245.73 2013 71 229 3 057.22 2 360.30 2014 71 837 3 032.88 2 243.05 2015 71 652 2 998.40 2 190.48 2016 77 040 3 212.18 2 049.18 2017 73 904 3 107.62 1 963.79 2018 78 009 3 290.18 2 005.22 2019 76 254 3 178.39 1 866.16 2020 77 438 3 213.46 1 868.53 2021 72 783 3 001.52 1 718.30 AAPC(%) − 0.30 −2.10 t值 − 1.20 −4.30 P值 − 0.268 < 0.001 注:AAPC. 平均年度变化百分比;YLL. 寿命损失年;−表示无数据 表 4 2010-2021年北京市海淀区户籍人口主要恶性肿瘤YLL率变化情况
Table 4. Change of YLL rate of major malignant tumors in local residents in Haidian district, Beijing city, from 2010 to 2021
主要疾病 YLL率(/10万) 标化YLL率(/10万) 2010年 2021年 AAPC(%) t值 P值 2010年 2021年 AAPC(%) t值 P值 肺癌 842.81 768.86 −0.30 −0.80 0.465 585.65 413.67 −3.00 −4.40 <0.001 结直肠癌 267.10 357.38 2.90 6.00 <0.001 183.27 192.44 0.20 0.40 0.720 肝癌 344.87 256.62 −2.70 −5.50 <0.001 267.44 148.83 −5.20 −10.70 <0.001 胃癌 261.06 226.20 −1.20 −3.40 0.007 183.37 130.82 −3.40 −6.10 <0.001 胰腺癌 183.76 202.39 2.60 3.70 0.004 128.38 114.56 0.10 0.10 0.919 乳腺癌 145.64 178.72 1.90 2.80 0.019 111.86 113.55 −0.10 −0.10 0.941 白血病 109.16 108.97 −1.40 −1.30 0.212 104.53 76.55 −4.50 −2.80 0.020 食管癌 88.06 89.25 −0.20 −0.20 0.872 61.74 49.99 −2.60 −2.40 0.036 脑及神经系统恶性肿瘤 96.89 81.50 −0.60 −0.50 0.631 96.61 63.11 −3.70 −2.20 0.054 卵巢癌 77.64 61.73 1.50 1.20 0.273 59.91 38.51 −0.70 −0.50 0.641 前列腺癌 50.07 55.55 1.40 2.10 0.062 30.47 22.19 −3.00 −1.50 0.136 膀胱癌 43.24 55.19 3.40 3.60 0.005 27.32 24.30 −0.80 −0.50 0.652 宫颈癌 24.30 31.90 2.50 2.00 0.077 17.86 22.67 3.40 1.10 0.257 注:AAPC. 平均年度变化百分比;YLL. 寿命损失年 -
[1] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1204–1222. DOI: 10.1016/S0140−6736(20)30925−9. [2] 中国疾病预防控制中心慢性非传染性疾病预防控制中心, 国家卫生健康委员会统计信息中心. 中国死因监测数据集-2021[M]. 北京: 中国科学技术出版社, 2022, 12: 27.Center for Chronic Noncommunicable Diseases, Chinese Center for Disease Control and Prevention, Information Statistics Center of the National Health Commission. China death surveillance data Set-2021[M]. Beijing: Science and Technology of China Press, 2022, 12: 27. [3] 北京市卫生健康大数据与政策研究中心, 北京市医院管理研究所. 2007年全市居民前十位死因顺位、死亡率及百分比构成[EB/OL]. (2008-08-15)[2022-12-03]. http://www.phic.org.cn/tjsj/wstjjb/2007nianjianbian/qsjmcsjbsswyyqk/200808/t20080815_256756.html.Beijing Municipal Health Big Data and Policy Research Center. Summary of statistics of health work in Beijing in 2007[EB/OL]. (2008-08-15)[2022-12-03]. http://www.phic.org.cn/tjsj/wstjjb/2007nianjianbian/qsjmcsjbsswyyqk/200808/t20080815_256756.html. [4] 李辉章, 杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J]. 中华预防医学杂志,2020,54(8):908–912. DOI:10.3760/cma.j.cn112150−20200616−00889.Li HZ, Du LB. Application of Joinpoint regression model in cancer epidemiological time trend analysis[J]. Chin J Prev Med, 2020, 54(8): 908–912. DOI: 10.3760/cma.j.cn112150−20200616−00889. [5] 北京市卫生健康委员会, 北京市卫生健康大数据与政策研究中心. 2021年北京卫生健康工作统计资料(简编)[EB/OL]. (2022-06-01)[2022-12-03]. http://www.phic.org.cn/tjsj/wstjjb/202206/P020220623625666785966.pdf.Beijing Municipal Commission of Health, Beijing Municipal Health Big Data and Policy Research Center. Summary of statistics of health work in Beijing in 2021[EB/OL]. (2022-06-01)[2022-12-03]. http://www.phic.org.cn/tjsj/wstjjb/202206/P020220623625666785966.pdf. [6] 高蓓, 初海超, 芦文丽, 等. 2004-2019年中国恶性肿瘤死亡趋势及预测分析[J]. 中华肿瘤防治杂志,2022,29(9):630–634. DOI: 10.16073/j.cnki.cjcpt.2022.09.03.Gao B, Chu HC, Lu WL, et al. Trend analysis and prediction of cancer mortality in China from 2004 to 2019[J]. Chin J Cancer Prev Treat, 2022, 29(9): 630–634. DOI: 10.16073/j.cnki.cjcpt.2022.09.03. [7] 李灿, 王静, 廖先珍, 等. 2014年-2018年湖南省肿瘤登记地区恶性肿瘤发病与死亡特征及变化趋势分析[J]. 肿瘤药学,2022,12(4):528–535. DOI:10.3969/j.issn.2095−1264.2022.04.17.Li C, Wang J, Liao XZ, et al. Analysis on the characteristics and trend of cancer incidence and mortality in the registered regions of Hunan province from 2014 to 2018[J]. Anti-Tumor Pharm, 2022, 12(4): 528–535. DOI: 10.3969/j.issn.2095−1264.2022.04.17. [8] 李丹, 周莹, 王联君, 等. 2007-2019年北京市东城区居民恶性肿瘤死亡流行趋势分析[J]. 中国肿瘤,2021,30(12):911–918. DOI:10.11735/j.issn.1004−0242.2021.12.A006.Li D, Zhou Y, Wang LJ, et al. Analysis on the trend of cancer mortality in Dongcheng district of Beijing from 2007 to 2019[J]. China Cancer, 2021, 30(12): 911–918. DOI: 10.11735/j.issn.1004−0242.2021.12.A006. [9] 孙晓伟, 苏彦萍, 张国峰, 等. 2010-2020年北京市通州区户籍居民恶性肿瘤死亡流行特征及减寿分析[J]. 预防医学情报杂志,2022,38(6):797–802,809. DOI:10.3969/j.issn.1006−4028.2022.6.yfyxqbzz202206012.Sun XW, Su YP, Zhang GF, et al. Analysis of death epidemic characteristics and years of life lost of malignant tumor among registered residents in Tongzhou district, Beijing from 2010 to 2020[J]. J Prev Med Inf, 2022, 38(6): 797–802,809. DOI: 10.3969/j.issn.1006−4028.2022.6.yfyxqbzz202206012. [10] 北京市老龄工作委员会办公室. 北京市2012年老年人口信息和老龄事业发展状况报告[EB/OL]. (2013-09-01)[2022-12-03]. http://mzj.beijing.gov.cn/attached/file/20180515/20180515154927_238.pdf.Office of Beijing Municipal Commission on Aging. Report on the elderly population information and the development of the cause of aging in Beijing in 2012[EB/OL]. (2013-09-01)[2022-12-03]. http://mzj.beijing.gov.cn/attached/file/20180515/20180515154927_238.pdf. [11] Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer[EB/OL]. (2020-12-01)[2022-12-03]. http://gco.iarc.fr/2020. [12] 解晔, 李秋梅, 杨文彬, 等. 江苏省扬州市1973-2019年居民恶性肿瘤死亡流行趋势分析[J]. 中国肿瘤,2021,30(2):119–123. DOI:10.11735/j.issn.1004−0242.2021.02.A003.Xie Y, Li QM, Yang WB, et al. Analysis on the trend of cancer mortality of Yangzhou residents from 1973 to 2019[J]. China Cancer, 2021, 30(2): 119–123. DOI: 10.11735/j.issn.1004−0242.2021.02.A003. [13] 傅晏红, 饶蓁蓁, 李若曈, 等. 2030年中国恶性肿瘤疾病负担预测研究与危险因素控制效果模拟[J]. 中华流行病学杂志,2022,43(1):37–43. DOI:10.3760/cma.j.cn112338−20210702−00517.Fu YH, Rao ZZ, Li RT, et al. Prediction of disease burden caused by malignant cancer in the context of risk factor control in China, 2030[J]. Chin J Epidemiol, 2022, 43(1): 37–43. DOI: 10.3760/cma.j.cn112338−20210702−00517. [14] 么鸿雁, 施侣元. 中国人群肺癌发病危险因素的Meta分析[J]. 中华流行病学杂志,2003,24(1):45–49. DOI:10.3760/j.issn:0254−6450.2003.01.013.Yao HY, Shi LY. Meta-analysis of the risk factors on lung cancer in Chinese people[J]. Chin J Epidemiol, 2003, 24(1): 45–49. DOI: 10.3760/j.issn:0254−6450.2003.01.013. [15] Wang N, Mengersen K, Tong SL, et al. Global, regional, and national burden of lung cancer and its attributable risk factors, 1990 to 2017[J]. Cancer, 2020, 126(18): 4220–4234. DOI: 10.1002/cncr.33078. [16] 郭晓雷, 付振涛, 孙建东, 等. 山东省1970-2013年恶性肿瘤死亡率变化趋势及差别分解[J]. 中华流行病学杂志,2019,40(8):924–929. DOI:10.3760/cma.j.issn.0254−6450.2019.08.010.Guo XL, Fu ZT, Sun JD, et al. Trend of mortality and decomposition on malignant tumors in Shandong province, 1970–2013[J]. Chin J Epidemiol, 2019, 40(8): 924–929. DOI: 10.3760/cma.j.issn.0254−6450.2019.08.010. [17] 黄钊慰, 薛明劲, 胡雨迪, 等. 1990-2019年中国结直肠癌归因于各类危险因素的疾病负担分析与模型预测[J]. 中华疾病控制杂志,2022,26(1):7–13. DOI: 10.16462/j.cnki.zhjbkz.2022.01.002.Huang ZW, Xue MJ, Hu YD, et al. Analysis and model prediction of disease burden attributable to various risk factors for colorectal cancer in China from 1990 to 2019[J]. Chin J Dis Control Prev, 2022, 26(1): 7–13. DOI: 10.16462/j.cnki.zhjbkz.2022.01.002. [18] 马佳鑫, 韦再华, 苏健婷, 等. 2010-2020年北京市女性乳腺癌死亡情况及趋势分析[J]. 疾病监测,2022,37(5):674–678. DOI: 10.3784/jbjc.202106100327.Ma JX, Wei ZH, Su JT, et al. Analysis on mortality and trend of breast cancer in women in Beijing, 2010–2020[J]. Dis Surveill, 2022, 37(5): 674–678. DOI: 10.3784/jbjc.202106100327. [19] 马爱娟, 周脉耕, 曾新颖, 等. 1990年与2016年北京市恶性肿瘤疾病负担及其变化趋势[J]. 中华肿瘤杂志,2021,43(3):351–356. DOI:10.3760/cma.j.cn112152−20190416−00239.Ma AJ, Zhou MG, Zeng XY, et al. The current status and trend of disease burden of neoplasms in 1990 and 2016 for Beijing people[J]. Chin J Oncol, 2021, 43(3): 351–356. DOI: 10.3760/cma.j.cn112152−20190416−00239. [20] 杨佳, 张楠, 杜振华, 等. 2013-2018年山东省肥城市主要恶性肿瘤的早死概率和疾病负担分析[J]. 中国肿瘤,2020,29(9):682–688. DOI:10.11735/j.issn.1004−0242.2020.09.A008.Yang J, Zhang N, Du ZH, et al. Analysis of probability of premature mortality and disease burden caused by major malignant tumors from 2013 to 2018 in Feicheng city, Shandong province[J]. China Cancer, 2020, 29(9): 682–688. DOI: 10.11735/j.issn.1004−0242.2020.09.A008. [21] 周海茸, 杨华凤, 陈旭鹏, 等. 2007-2018年南京市居民恶性肿瘤疾病负担分析[J]. 中国慢性病预防与控制,2020,28(5):350–354. DOI:10.16386/j.cjpccd.issn.1004−6194.2020.05.007.Zhou HR, Yang HF, Chen XP, et al. Analysis on disease burden of malignant tumor in residents of Nanjing from 2007 to 2018[J]. Chin J Prev Control Chron Dis, 2020, 28(5): 350–354. DOI: 10.16386/j.cjpccd.issn.1004−6194.2020.05.007. [22] 文小焱, 潘惊萍, 段占祺, 等. 2013-2017年四川省居民恶性肿瘤疾病负担研究[J]. 中国肿瘤,2020,29(10):758–762. DOI:10.11735/j.issn.1004−0242.2020.10.A007.Wen XY, Pan JP, Duan ZQ, et al. Disease burden of malignant tumor in Sichuan province, 2013–2017[J]. China Canner, 2020, 29(10): 758–762. DOI: 10.11735/j.issn.1004−0242.2020.10.A007. [23] Wang JB, Jiang Y, Liang H, et al. Attributable causes of cancer in China[J]. Ann Oncol, 2012, 23(11): 2983–2989. DOI: 10.1093/annonc/mds139. -